Behavioral Intervention for Low Income Depressed Smokers in Drug Treatment
| Status: | Completed |
|---|---|
| Conditions: | Depression, Smoking Cessation |
| Therapuetic Areas: | Psychiatry / Psychology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 4/2/2016 |
| Start Date: | January 2011 |
| End Date: | December 2014 |
| Contact: | Laura MacPherson, PhD |
| Email: | lmacpherson@psyc.umd.edu |
The objective of the proposed project is to develop a novel, behavioral approach to smoking
cessation that can be integrated with residential drug use treatment for low income
substance using smokers with elevated depressive symptoms. The approach utilizes behavioral
activation strategies which have been shown to reduce smoking among community samples and
which can be easily targeted for the particular needs of low income substance users.
cessation that can be integrated with residential drug use treatment for low income
substance using smokers with elevated depressive symptoms. The approach utilizes behavioral
activation strategies which have been shown to reduce smoking among community samples and
which can be easily targeted for the particular needs of low income substance users.
This project will take place in two phases. In the first phase, the investigators will
utilize pilot testing with 10 participants (two groups of 5 individuals) to integrate two
existing behavioral activation manuals to develop the Behavioral Activation for Drug Abusing
Smokers (BA-DAS). In Phase II, the investigators will randomize 80 patients to either: 1)
standard smoking cessation treatment (ST) and nicotine replacement therapy (NRT) or 2)
BA-DAS (which includes ST and NRT). Based on the outcome of this preliminary trial, the
BA-DAS protocol will be further refined and readied for larger-scale clinical trials to
develop a comprehensive approach to treating smoking among low income, largely minority,
depressed smokers in residential drug use treatment, which may be instrumental in reducing
smoking among this especially at risk group.
utilize pilot testing with 10 participants (two groups of 5 individuals) to integrate two
existing behavioral activation manuals to develop the Behavioral Activation for Drug Abusing
Smokers (BA-DAS). In Phase II, the investigators will randomize 80 patients to either: 1)
standard smoking cessation treatment (ST) and nicotine replacement therapy (NRT) or 2)
BA-DAS (which includes ST and NRT). Based on the outcome of this preliminary trial, the
BA-DAS protocol will be further refined and readied for larger-scale clinical trials to
develop a comprehensive approach to treating smoking among low income, largely minority,
depressed smokers in residential drug use treatment, which may be instrumental in reducing
smoking among this especially at risk group.
Inclusion Criteria:
- between 18 and 65 years of age
- regular smoker for at least one year
- currently smoking an average ≥ 10 cigarettes (also cigarellos, bidis, or Black and
Milds included) per day
- report motivation to quit smoking in the next month
- report elevated depressive symptoms
Exclusion Criteria:
- physical concerns contraindicating the nicotine patch
- limited mental competency and/or the inability to give informed, voluntary, written
consent to participate
- current use of pharmacotherapy for smoking cessation not provided by the researchers
during the quit attempt
- use of psychotropic medication for < 3 months
- primary use of other tobacco products (specifically: chewing tobacco, cigars, and
pipes)
- psychotic symptoms
- current pregnancy or plans to become pregnant within the following three months
We found this trial at
1
site
Click here to add this to my saved trials
